TSE:4530Pharmaceuticals
Hisamitsu Pharmaceutical (TSE:4530) Valuation After Dividend Cancellation And Recent Share Price Performance
Hisamitsu Pharmaceutical (TSE:4530) told investors it will pay no dividend for the fiscal year ended February 28, 2026. The decision puts the spotlight on how management is prioritising cash use.
See our latest analysis for Hisamitsu Pharmaceutical.
The decision to cancel the dividend comes after a mixed price pattern, with the latest share price at ¥6,044 and a year to date share price return of 34.31% alongside a 1 year total shareholder return of 36.67%. This hints that longer term...